Galectin 9, CXCL-10 and tumor necrosis factor receptor type II as biomarkers of disease activity in systemic lupus erythematosus.

  1. Gensous, N, Vagner, D, Barnetche, T, Duffau, P, Lazaro, E, Richez, C et al.. Galectin 9, CXCL-10 and tumor necrosis factor receptor type II as biomarkers of disease activity in systemic lupus erythematosus. Joint Bone Spine. 2022;89 (3):105311. doi: 10.1016/j.jbspin.2021.105311. PubMed PMID:34838990 .
Search PubMed

People Involved

All right reserved © immunoconcept.cnrs.fr 2022 by Nivo-Web

Scroll to Top